- VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business Update
- VolitionRx Limited Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call and Business Update
- Volition and Fujifilm Vet Systems Launch Nu.Q® Vet Cancer Test in Japan
- Volition appoints Dr Andrew Retter as Chief Medical Officer
- Volition to Share Nu.Q® NETs Strategy Update at Upcoming Webinar
More ▼
Key statistics
On Friday, VolitionRX Ltd (VNRX:ASQ) closed at 0.616, 12.00% above the 52 week low of 0.55 set on Dec 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.63 |
---|---|
High | 0.65 |
Low | 0.57 |
Bid | 0.5903 |
Offer | 0.7457 |
Previous close | 0.6172 |
Average volume | 130.43k |
---|---|
Shares outstanding | 82.07m |
Free float | 62.44m |
P/E (TTM) | -- |
Market cap | 50.55m USD |
EPS (TTM) | -0.504 USD |
Data delayed at least 15 minutes, as of Apr 19 2024 21:10 BST.
More ▼